Analyst Ratings for Morphic Therapeutic (MORF) [Buys]
MORF Rating Summary
MORF Price Target Summary
- Highest: $76.00 (RBC Capital)
- Lowest: $27.00 (Stifel)
- Average: $58.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$58.25 (+104.4%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$58.25 (+104.4%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/8/2023 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
46.00 (N/A) |
25.78 (28.50) |
10.55% | Details |
| 7/20/2023 | Berenberg | Guarav Goparaju | New Coverage | Buy (N/A) |
75.00 (N/A) |
54.97 (28.50) |
-48.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
